Amy DuRoss, Co-Founder and CEO

Oct. 13 | 5:00pm | BlueRock Therapeutics Ballroom

San Francisco, CA


Vineti creates the essential software solution to drive and scale personalized therapies, such as cell and gene therapies. Our leading Personalized Therapy Management® platform delivers simplicity, compliance, and patient safety to medicine’s most complex supply chain, providing the next-generation technology that advanced therapies need. Vineti combines leading enterprise software expertise with deep, first-hand biopharma experience to develop a cloud-based platform of record that ensures quality, scale, security, efficiency, traceability, and patient safety. The Vineti platform also provides actionable insights to continually optimize the therapy process, accelerating time to revenue and decreasing costs. The PTM® platform supports both autologous and allogeneic therapeutics, as well as personalized cancer vaccines. Vineti serves biopharmaceutical developers at any stage, and offers the only enterprise platform supporting successful cell therapy approvals in the U.S. and EU. Vineti supports hundreds of medical centers worldwide and has been honored as a World Economic Forum Technology Pioneer.

By using this website you agree to accept our Privacy Policy and Terms & Conditions